Latest Breaking News On - Gilead public affairs - Page 1 : vimarsana.com

Gilead Sciences, Inc : Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024

Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease - Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research

Foster cityUnited statesFrank duffJacquie rossEpatitec mettiamociMeaghan smithGilead on twitter sciencesGilead sciences in liver diseaseGilead sciencesLove your liver campaignDrug administrationEuropean commissionGilead public affairsExchange commissionGilead sciences incWorld health organization

Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024

Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United arab emiratesUnited statesFoster citySanta monicaMato grosso do sulDomvanalimab domBrexucabtagene autoleucelAxicabtagene ciloleucelSacituzumab govitecanBig ten cancer research consortium studyGilead sciences incGilead sciencesEuropean unionDana farber cancer instituteGilead public affairsGuangzhou gloria biosciences co

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Foster cityUnited statesLang schwarzIhre einschGilead sciences to release first quarterGilead sciencesGilead public affairsGilead sciences incGilead sciences stockRelease first quarterInvestor relationsSie ihre einschBeachten sie

FDA Expands Indication for Gilead s Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

FDA Expands Indication for Gilead s Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFoster cityJacquie rossChaun hao linMeaghan smithFrank duffGilead sciences incGilead public affairsRisk of developmentExchange commissionDrug administrationGilead pediatric centerGilead sciences in liver diseaseGilead sciencesSafety profileOnce daily vemlidy demonstrated

Gilead Sciences with Emma s Story: Self-Advocacy in Breast Cancer

NORTHAMPTON, MA / ACCESSWIRE / January 16, 2024 / "It's an experience that I hope no one goes through, but it's an empowering experience."When Emma was diagnosed with breast cancer, she felt "pushed aside" due to her age. Hear more about how she advocated for herself with the support of her famil.

United statesFoster cityGilead sciencesGilead on twitter sciencesGilead public affairsGilead sciences inc